Show
Sort by
-
- Journal Article
- A1
- open access
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis : a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR
-
Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility
-
- Journal Article
- A1
- open access
Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis : results from the ASAS-COMOSPA study
-
- Journal Article
- A1
- open access
Induction of sustained clinical remission in early axial spondyloarthritis following certolizumab pegol treatment : 48-week outcomes from C-OPTIMISE
-
- Journal Article
- A1
- open access
Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease : data from the Swiss Clinical Quality Management cohort
-
- Journal Article
- A1
- open access
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)
-
Prevalence of comorbidities and risk factors for comorbidities in patients with spondyloarthritis in Latin America : a comparative study with the general population and data from the ASAS-COMOSPA study
-
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological diseasemodifying anti-rheumatic drugs (COAST-V) : 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
-
- Journal Article
- A1
- open access
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target : 2017 update of recommendations by an international task force
-
- Journal Article
- A1
- open access
The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study
-
- Journal Article
- A2
- open access
Efficacy and safety of biological and targeted-synthetic DMARDs : a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
-
- Journal Article
- A2
- open access
Efficacy and safety of non-pharmacological and non-biological pharmacological treatment : a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
-
- Journal Article
- A1
- open access
Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis : 4-year outcomes from RAPID-axSpA
-
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
-
Gender-attributable differences in outcome of ankylosing spondylitis : long-term results from the Outcome in Ankylosing Spondylitis International Study
-
Defining active sacroiliitis on MRI for classification of axial spondyloarthritis : update by the ASAS MRI working group
-
Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort : a final analysis
-
Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study
-
Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS
-
- Journal Article
- A1
- open access
Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis
-
Prevalence of comorbidities and evaluation of their screening in spondyloarthritis : results of the international cross-sectional ASAS-COMOSPA study
-
- Journal Article
- A2
- open access
Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis : a longitudinal analysis
-
How to deal with missing items in BASDAI and BASFI
-
Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort
-
A physically demanding job may amplify the effect of disease activity on the development of syndesmophytes in patients with ankylosing spondylitis
-
Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the outcome in ankylosing spondylitis international study
-
Do extra-articular manifestations influence outcome in ankylosing spondylitis?: a 12 year follow-up study
-
Aspects of validity of the self-administered comorbidity questionnaire in patients with ankylosing spondylitis
-
- Journal Article
- A1
- open access
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
-
Are syndesmophytes most prevalent in the lumbar or in the cervical spine in patients with ankylosing spondylitis and do they develop in a specific direction?
-
Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study